These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 9452361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D, Gerfaux J, Joret AM, Chany C.
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
    [Abstract] [Full Text] [Related]

  • 4. Presence of a constitutive paracrine beta-interferon in v-mos-bearing nonmalignant reverted cells.
    Gerfaux J, Sergiescu D, Fournier JG, Pochart F, Joret AM, Chany C.
    Cancer Res; 1989 Mar 01; 49(5):1241-6. PubMed ID: 2521813
    [Abstract] [Full Text] [Related]

  • 5. Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells.
    Offermann MK, Faller DV.
    Cancer Res; 1990 Feb 01; 50(3):601-5. PubMed ID: 2105158
    [Abstract] [Full Text] [Related]

  • 6. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
    Douvdevani A, Huleihel M, Segal S, Apte RN.
    Eur Cytokine Netw; 1991 Feb 01; 2(4):257-64. PubMed ID: 1756231
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoid modulation of transformed cell proliferation is oncogene specific and correlates with effects on c-myc levels.
    O'Banion MK, Levenson RM, Brinckmann UG, Young DA.
    Mol Endocrinol; 1992 Sep 01; 6(9):1371-80. PubMed ID: 1331773
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha affects LTR-controlled oncogene expression in transformed mouse fibroblasts at the post-transcriptional level.
    Seliger B, Stark G, Pfizenmaier K.
    J Immunol; 1988 Sep 15; 141(6):2138-44. PubMed ID: 2844896
    [Abstract] [Full Text] [Related]

  • 9. R7, a spontaneous mutant of Moloney murine sarcoma virus 124 with three direct repeats and an in-frame truncated gag-mos gene, induces brain lesions.
    Yuen PH, Kwak YT.
    Virology; 1997 Sep 15; 236(1):213-8. PubMed ID: 9299634
    [Abstract] [Full Text] [Related]

  • 10. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ, Marx M, Calothy G, Blair DG.
    Cell Growth Differ; 1995 Jan 15; 6(1):27-38. PubMed ID: 7718484
    [Abstract] [Full Text] [Related]

  • 11. Distinct mechanisms of interferon-gamma and tumor necrosis factor-alpha action in oncogene-transformed mouse fibroblasts.
    Seliger B, Killian M, Pfizenmaier K.
    J Cell Biochem; 1988 Nov 15; 38(3):205-12. PubMed ID: 3147985
    [Abstract] [Full Text] [Related]

  • 12. Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells.
    Wang S, Nishigori C, Miyakoshi J, Tsukada T, Shung B, Yagi T, Takebe H.
    Oncogene; 1993 Apr 15; 8(4):1009-16. PubMed ID: 8455928
    [Abstract] [Full Text] [Related]

  • 13. Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
    Blair DG, Cooper CS, Oskarsson MK, Eader LA, Vande Woude GF.
    Prog Clin Biol Res; 1983 Apr 15; 119():79-90. PubMed ID: 6346333
    [Abstract] [Full Text] [Related]

  • 14. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
    Ohuchi T, Kurita Y, Sasai H, Miyoshi J, Nomura T, Toyoshima K.
    Oncogene; 1992 Feb 15; 7(2):331-8. PubMed ID: 1532243
    [Abstract] [Full Text] [Related]

  • 15. Characterization of transformation function of cottontail rabbit papillomavirus E5 and E8 genes.
    Han R, Cladel NM, Reed CA, Christensen ND.
    Virology; 1998 Nov 25; 251(2):253-63. PubMed ID: 9837789
    [Abstract] [Full Text] [Related]

  • 16. Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts.
    Contente S, Attard FA, Yeh TJ, Buchhagen DL, Friedman RM.
    J Interferon Cytokine Res; 2003 Nov 25; 23(11):639-47. PubMed ID: 14651778
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 25; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 18. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M, Bryant MS, Chen J, Lee S, Yaremko B, Li Z, Dell J, Lipari P, Malkowski M, Prioli N, Rossman RR, Korfmacher WA, Nomeir AA, Lin CC, Mallams AK, Doll RJ, Catino JJ, Girijavallabhan VM, Kirschmeier P, Bishop WR.
    Cancer Chemother Pharmacol; 1999 Apr 25; 43(1):50-8. PubMed ID: 9923541
    [Abstract] [Full Text] [Related]

  • 19. Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
    Paules RS, Resnick J, Kasenally AB, Ernst MK, Donovan P, Vande Woude GF.
    Oncogene; 1992 Dec 25; 7(12):2489-98. PubMed ID: 1461652
    [Abstract] [Full Text] [Related]

  • 20. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
    Lauret E, Riviere I, Rousseau V, Vieillard V, De Maeyer-Guignard J, De Maeyer E.
    Hum Gene Ther; 1993 Oct 25; 4(5):567-77. PubMed ID: 8280795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.